Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 73 of 159 for:    colon cancer AND Capecitabine AND Fluorouracil

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01308086
Recruitment Status : Unknown
Verified August 2017 by Hellenic Oncology Research Group.
Recruitment status was:  Active, not recruiting
First Posted : March 3, 2011
Last Update Posted : August 9, 2017
Sponsor:
Collaborator:
University Hospital of Crete
Information provided by (Responsible Party):
Hellenic Oncology Research Group

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : November 2017
Estimated Study Completion Date : December 2017